Rina Chin

Safety and efficacy of tirzepatide as an add-on to single oral antihyperglycaemic medication in patients with type 2 diabetes in Japan (SURPASS J-combo): a multicentre, randomised, open-label, parallel-group, phase 3 trial

Takashi Kadowaki, Rina Chin, Akichika Ozeki et al. · The Lancet Diabetes & Endocrinology · 2022 · 124 citations

Medicine, Pharmacology, Pharmacotherapy +15

Circulating levels of ganglioside GM3 in metabolic syndrome: A pilot study

Takashige Sato, Yutaka Nihei, Masakazu Nagafuku et al. · Obesity Research & Clinical Practice · 2008 · 47 citations

Life Sciences, Biochemistry, Clinical Biochemistry +11

Effect of Ezetimibe on LDL-C Lowering and Atherogenic Lipoprotein Profiles in Type 2 Diabetic Patients Poorly Controlled by Statins

Kentaro Q. Sakamoto, Mitsunobu Kawamura, Takahide Kohro et al. · PLoS ONE · 2015 · 31 citations · Full text

Pharmacy, Pharmacology, Pharmacotherapy +17

The impact of a low glycaemic index (GI) diet on simultaneous measurements of blood glucose and fat oxidation: A whole body calorimetric study

Bhupinder Kaur, Rina Chin, Stefan Gerardus Camps et al. · Journal of Clinical & Translational Endocrinology · 2016 · 31 citations · Full text

Life Sciences, Nutrition, Nutritional Sciences +17

Cost-effectiveness Analysis of Empagliflozin in Japan Based on Results From the Asian subpopulation in the EMPA-REG OUTCOME Trial

Kohei Kaku, Masakazu Haneda, Hiroyuki Sakamaki et al. · Clinical Therapeutics · 2019 · 29 citations

Pharmacy, Pharmacoeconomics, Pharmacotherapy +17